Delivery Order SPE2DB20D1100-SPE2DB25FE0TZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Latuda 40 mg tablets (30-count units) valued at $7,754.48 under a firm fixed price contract structure. This non-set-aside award was competitively procured and is scheduled for completion by July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will fulfill this order...
- The Defense Logistics Agency awarded a delivery order valued at $9,844.52 to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count packages) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded transaction under the company's broader pharmaceutical supply relationships with the federal government. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $6,978.90 delivery order to AmerisourceBergen Drug Corp for Latuda 40 mg tablets (30-count units) on September 18, 2025, with a completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Latuda 60 mg tablets (30-count units) with a ceiling value of $29,470.00 under firm fixed pricing. This non-set-aside, competitively awarded delivery order is scheduled for completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 2, 2025, for the supply of Latuda 60 mg tablets (30-count packaging) with a ceiling value of $6,445.00 under a firm fixed price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December 2026. The order is to be fulfilled...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Latuda 20 mg tablets in a quantity of 30 units. This competitive award, valued at $15,367.79, carries a firm fixed price structure with an ultimate completion date of August 29, 2025. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count) with a ceiling value of $5,207.81. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of August 26, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count) with a ceiling value of $41,891.62. This firm fixed-price contract, awarded on September 8, 2025, with a completion date of September 9, 2025, represents a non-competitive set-aside delivery order issued under DLA's broader pharmaceutical procurement framework. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count) on September 25, 2025, with a ceiling value of $19,403.50. This is a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,787.95 to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count units) under a firm fixed price arrangement. The order was competitively awarded without set-aside designation and is scheduled for completion by May 7, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. This delivery order represents a child contract action under AmerisourceBergen's larger...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0TZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Latuda 40 mg tablets (quantity: 30 units) under a firm fixed price contract with a ceiling value of $10,349.66. The order is scheduled for completion by September 23, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a single-line procurement from the vendor's broader pharmaceutical supply portfolio. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical federal vendor supplying medications, vaccines, and medical supplies to military and veteran healthcare systems. The Latuda order supports the Defense Health Agency and other federal healthcare customers through the company's comprehensive global pharmaceutical support vehicle, which enables flexible procurement of specialty medications and generic drugs across multiple therapeutic domains for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 9/22/25 |